Skip to main content
PMC home page
PLOS ONE logoLink to PLOS ONE
. 2018 Nov 12;13(11):e0207586. doi: 10.1371/journal.pone.0207586

Correction: Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell Stemness

Gorka Ruiz de Garibay, Carmen Herranz, Alicia Llorente, Jacopo Boni, Jordi Serra-Musach, Francesca Mateo, Helena Aguilar, Laia Gómez-Baldó, Anna Petit, August Vidal, Fina Climent, Javier Hernández-Losa, Álex Cordero, Eva González-Suárez, José Vicente Sánchez-Mut, Manel Esteller, Roger Llatjós, Mar Varela, José Ignacio López, Nadia García, Ana I Extremera, Anna Gumà, Raúl Ortega, María Jesús Plà, Adela Fernández, Sònia Pernas, Catalina Falo, Idoia Morilla, Miriam Campos, Miguel Gil, Antonio Román, María Molina-Molina, Piedad Ussetti, Rosalía Laporta, Claudia Valenzuela, Julio Ancochea, Antoni Xaubet, Álvaro Casanova, Miguel Angel Pujana
PMCID: PMC6231678  PMID: 30419005

The following information is missing from the Funding section: This study was supported by the Spanish Ministry of Science and Innovation, European Regional Development Fund (FEDER).

Reference

  • 1.Ruiz de Garibay G, Herranz C, Llorente A, Boni J, Serra-Musach J, Mateo F, et al. (2015) Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell Stemness. PLoS ONE 10(7): e0132546 10.1371/journal.pone.0132546 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES